Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
16,470,895
-
Total 13F shares
-
5,308,429
-
Share change
-
+5,232,724
-
Total reported value
-
$61,441,352
-
Price per share
-
$11.57
-
Number of holders
-
54
-
Value change
-
+$60,565,445
-
Number of buys
-
52
Institutional Holders of SUTRO BIOPHARMA, INC. - Common Stock, $0.001 par value (STRO) as of Q4 2025
As of 31 Dec 2025,
SUTRO BIOPHARMA, INC. - Common Stock, $0.001 par value (STRO) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,308,429 shares.
The largest 10 holders included
Affinity Asset Advisors, LLC, Kynam Capital Management, LP, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, Velan Capital Investment Management LP, Vestal Point Capital, LP, Balyasny Asset Management L.P., SAMSARA BIOCAPITAL, LLC, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This page lists
54
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.